-transparent.png){kind=logo}
The effect of alphaxalon + alphadolon-acetate on cerebrospinal fluid pressure (CSFP), mean arterial blood pressure (MPA), heart rate (BMP) and blood gases was investigated in 18 patients. Cerebral perfusion pressure (CPP) was calculated from the difference MAP minus CSFP. Alphaxalon + alphadolon-acetate lowered the normal CSFP and normalized ketamin induced increase of CSFP. Premedication with alphaxalon + alphadolon-acetate delayed the ketamin induced increase of CSFP, which returned to norm after a second dose of alphaxalon + alphadolon-acetate. This effect was seen despite elevation of pCO2 in all patients breathing spontaneously.
Related Publications
E Ekhart, and
W F List, and
P Vadon, and
R Oberbauer
May 1980,
Ugeskrift for laeger,
E Ekhart, and
W F List, and
P Vadon, and
R Oberbauer
November 1975,
Anaesthesia,
E Ekhart, and
W F List, and
P Vadon, and
R Oberbauer
July 1999,
The Veterinary record,
E Ekhart, and
W F List, and
P Vadon, and
R Oberbauer
February 1973,
British journal of anaesthesia,
E Ekhart, and
W F List, and
P Vadon, and
R Oberbauer
July 1981,
The Journal of pharmacy and pharmacology,
E Ekhart, and
W F List, and
P Vadon, and
R Oberbauer
January 1980,
Fortschritte der Medizin,
E Ekhart, and
W F List, and
P Vadon, and
R Oberbauer
January 1988,
Journal of medical primatology,
E Ekhart, and
W F List, and
P Vadon, and
R Oberbauer
July 1947,
The American journal of the medical sciences,
E Ekhart, and
W F List, and
P Vadon, and
R Oberbauer
October 2007,
Pediatrics,
E Ekhart, and
W F List, and
P Vadon, and
R Oberbauer
March 1955,
The Journal of endocrinology,
